Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Effects of high glucose and high insulin concentrations on osteoblast function in vitro.

Cunha JS, Ferreira VM, Maquigussa E, Naves MA, Boim MA.

Cell Tissue Res. 2014 Oct;358(1):249-56. doi: 10.1007/s00441-014-1913-x. Epub 2014 May 25.

PMID:
24859221
2.

PTH differentially regulates expression of RANKL and OPG.

Huang JC, Sakata T, Pfleger LL, Bencsik M, Halloran BP, Bikle DD, Nissenson RA.

J Bone Miner Res. 2004 Feb;19(2):235-44. Epub 2003 Dec 16.

3.

High glucose concentrations alter the biomineralization process in human osteoblastic cells.

García-Hernández A, Arzate H, Gil-Chavarría I, Rojo R, Moreno-Fierros L.

Bone. 2012 Jan;50(1):276-88. doi: 10.1016/j.bone.2011.10.032. Epub 2011 Nov 7.

PMID:
22086137
4.

The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.

Peng S, Liu XS, Huang S, Li Z, Pan H, Zhen W, Luk KD, Guo XE, Lu WW.

Bone. 2011 Dec;49(6):1290-8. doi: 10.1016/j.bone.2011.08.031. Epub 2011 Sep 9.

PMID:
21925296
5.

Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.

Luppen CA, Smith E, Spevak L, Boskey AL, Frenkel B.

J Bone Miner Res. 2003 Jul;18(7):1186-97.

7.

Metformin rescues the MG63 osteoblasts against the effect of high glucose on proliferation.

Shao X, Cao X, Song G, Zhao Y, Shi B.

J Diabetes Res. 2014;2014:453940. doi: 10.1155/2014/453940. Epub 2014 Apr 9.

8.
9.

Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts.

Kitamura K, Takahira K, Inari M, Satoh Y, Hayakawa K, Tabuchi Y, Ogai K, Nishiuchi T, Kondo T, Mikuni-Takagaki Y, Chen W, Hattori A, Suzuki N.

Comp Biochem Physiol A Mol Integr Physiol. 2013 Sep;166(1):74-80. doi: 10.1016/j.cbpa.2013.04.023. Epub 2013 Apr 28.

PMID:
23632157
11.

Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development.

Quarles LD, Yohay DA, Lever LW, Caton R, Wenstrup RJ.

J Bone Miner Res. 1992 Jun;7(6):683-92.

PMID:
1414487
12.

Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages.

Gopalakrishnan V, Vignesh RC, Arunakaran J, Aruldhas MM, Srinivasan N.

Biochem Cell Biol. 2006 Feb;84(1):93-101.

PMID:
16462893
13.

Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice.

Cao J, Venton L, Sakata T, Halloran BP.

J Bone Miner Res. 2003 Feb;18(2):270-7.

14.

Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.

Irie A, Takami M, Kubo H, Sekino-Suzuki N, Kasahara K, Sanai Y.

Bone. 2007 Aug;41(2):165-74. Epub 2007 May 5.

PMID:
17560185
16.

Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio.

Rucci N, Rufo A, Alamanou M, Teti A.

J Cell Biochem. 2007 Feb 1;100(2):464-73.

PMID:
16927271
17.
18.

Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts.

Yonou H, Horiguchi Y, Ohno Y, Namiki K, Yoshioka K, Ohori M, Hatano T, Tachibana M.

Prostate. 2007 Jun 1;67(8):840-8.

PMID:
17394194
19.

High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage.

Geoffroy V, Kneissel M, Fournier B, Boyde A, Matthias P.

Mol Cell Biol. 2002 Sep;22(17):6222-33.

20.

Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL.

Bord S, Frith E, Ireland DC, Scott MA, Craig JI, Compston JE.

Bone. 2005 May;36(5):812-9. Epub 2005 Mar 24.

PMID:
15794927

Supplemental Content

Support Center